Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Montana Psychiatry & Brain Health Center Joins Turnwell Mental Health Network in New Growth Partnership
Turnwell Mental Health Network and Montana Psychiatry & Brain Health Center (“Montana Psychiatry”), a leading provider […]
EIB and MedinCell Sign a New €40 Million Loan Agreement to Support Development of Innovative Treatments
European Investment Bank (EIB), backed by the Investment Plan for Europe, and pharmaceutical company MedinCell, […]
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology for Large-scale Exosome Production
Sartorius BIA Separations, a leading bio-chromatography company, now part of the international life science group […]
Regeneron and CytomX Announce Strategic Research Collaboration for Cancer Treatment
Regeneron Pharmaceuticals and CytomX Therapeutics has announced a collaboration and licensing agreement to create conditionally-activated […]
Navamedic ASA Acquires Innovative Antibiotics Product for Hospital Use in the Nordic Region
Navamedic has signed an agreement with its partner InfoRLife SA (subsidiary of ACS Dobfar S.p.A.) […]
FUJIFILM Healthcare Europe partners with The Royal College of Surgeons of Edinburgh
FUJIFILM Healthcare Europe, a leading provider of medical imaging solutions, has become an organisational partner […]
Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network
Vial has added NEXT Oncology to their Preferred Site Network (PSN). Founded by renowned oncologist Dr. Anthony W. […]
MUSC Health Selects UpStream Healthcare as its Value-Based Partner for Medicare Patients
The Medical University of South Carolina (MUSC Health) and national value-based healthcare company, UpStream Healthcare, have […]
Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.
Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and […]
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics
Sciwind Biosciences, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more